- $31.94m
- $307.02m
- $212.37m
- 10
- 65
- 22
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 182 | 148 | 231 | 252 | 212 |
Cost of Revenue | |||||
Gross Profit | 98.2 | 75.8 | 133 | 140 | 60.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 194 | 171 | 222 | 325 | 355 |
Operating Profit | -12.1 | -22.8 | 9.02 | -72.6 | -143 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.3 | -23.4 | 3.38 | -80.7 | -149 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.3 | -23.9 | 2.06 | -82.3 | -151 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.3 | -23.9 | 2.06 | -82.3 | -151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.3 | -23.9 | 2.06 | -82.3 | -151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.876 | -1.4 | -0.135 | -3.2 | -7.59 |